Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1982 Jul;76(3):423–438. doi: 10.1111/j.1476-5381.1982.tb09236.x

Antagonism of the thromboxane-sensitive contractile systems of the rabbit aorta, dog saphenous vein and guinea-pig trachea

RL Jones, V Peesapati, NH Wilson
PMCID: PMC2071809  PMID: 6286023

Abstract

1 The thromboxane-sensitive contractile systems in spirally-cut preparations of the rabbit aorta, dog saphenous vein and guinea-pig trachea have been compared. The full or partial agonist activities of a range of bicyclic ring analogues were found to be remarkably similar on the three preparations. In addition, EP 045, a prostanoid with a phenylsemicarbazone ω-chain, blocked the action of both thromboxane A2 (TXA2) and the bicyclic ring analogues. Using 11,9-epoxymethano prostaglandin H2 as the agonist, linear Schild plots with slopes close to unity were obtained on each preparation; this suggests a competitive type of antagonism.

2 Analogues of prostaglandin D2 (PGD2), PGE2 and PGF2α also contracted the three smooth muscle preparations; those analogues containing a 16-p-halophenoxy residue were highly active. On the rabbit aorta, EP 045 completely blocked the contractile actions of these agonists, perhaps indicating a single type of prostanoid receptor in this tissue. On the dog saphenous vein PGD2, PGE2 and 15-methyl PGE2 exhibited relaxant activity when the tissue was partially contracted with either a thromboxane agonist or noradrenaline. On the guinea-pig trachea 16,16-dimethyl PGE2 and the 16-p-chlorophenoxy analogue of PGE2 were potent contractile agents whose action was not blocked by EP 045. PGE2 and 15-methyl PGE2 showed similar properties but exhibited relaxant activity with increasing concentrations in the organ bath. Our results indicate the presence of three types of prostanoid receptors in the guinea-pig trachea: thromboxane- and PGE-sensitive systems mediating contraction and a PGE-sensitive system mediating relaxation.

3 The similarity of the thromboxane-sensitive systems in the three smooth muscle preparations is discussed with particular reference to the differences in the equilibrium dissociation constants for EP 045.

Full text

PDF
423

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Apperley E., Feniuk W., Humphrey P. P., Levy G. P. Evidence for two types of excitatory receptor for 5-hydroxytryptamine in dog isolated vasculature. Br J Pharmacol. 1980 Feb;68(2):215–224. doi: 10.1111/j.1476-5381.1980.tb10410.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brash A. R., Jones R. L. Straight phase separation of prostaglandin methyl esters on lipophilic gels. Prostaglandins. 1974 Mar 10;5(5):441–454. doi: 10.1016/s0090-6980(74)80014-6. [DOI] [PubMed] [Google Scholar]
  3. Coleman R. A., Humphrey P. P., Kennedy I., Levy G. P., Lumley P. Comparison of the actions of U-46619, a prostaglandin H2-analogue, with those of prostaglandin H2 and thromboxane A2 on some isolated smooth muscle preparations. Br J Pharmacol. 1981 Jul;73(3):773–778. doi: 10.1111/j.1476-5381.1981.tb16814.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Corey E. J., Narasaka K., Shibasaki M. A direct,stereocontrolled total synthesis of the 9,11-azo analogue of the prostaglandin endoperoxide, PGH2. J Am Chem Soc. 1976 Sep 29;98(20):6417–6418. doi: 10.1021/ja00436a074. [DOI] [PubMed] [Google Scholar]
  5. Dong Y. J., Jones R. L. Effects of prostaglandins and thromboxane analogues on bullock and dog iris sphincter preparations. Br J Pharmacol. 1982 May;76(1):149–155. doi: 10.1111/j.1476-5381.1982.tb09200.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Farmer J. B., Farrar D. G., Wilson J. Antagonism of tone and prostaglandin-mediated responses in a tracheal preparation by indomethacin and SC-19220. Br J Pharmacol. 1974 Dec;52(4):559–565. doi: 10.1111/j.1476-5381.1974.tb09724.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Gardiner P. J., Collier H. O. Specific receptors for prostaglandins in airways. Prostaglandins. 1980 Jun;19(6):819–841. doi: 10.1016/0090-6980(80)90116-1. [DOI] [PubMed] [Google Scholar]
  8. James G. W. The use of the in vivo trachea preparation of the guinea-pig to asses drug action on lung. J Pharm Pharmacol. 1969 Jun;21(6):379–386. doi: 10.1111/j.2042-7158.1969.tb08271.x. [DOI] [PubMed] [Google Scholar]
  9. Jones R. L. Cardiovascular actions of prostaglandins D and E in the sheep: evidence for two distinct receptors. Adv Prostaglandin Thromboxane Res. 1976;1:221–230. [PubMed] [Google Scholar]
  10. Jones R. L. Definition of prostaglandin-sensitive arterial constrictor systems. Acta Biol Med Ger. 1978;37(5-6):837–844. [PubMed] [Google Scholar]
  11. Jones R. L., Marr C. G. Actions of 16-aryloxy analogues of prostaglandin F2alpha on preparations responsive to prostaglandin endoperoxides. Br J Pharmacol. 1977 Dec;61(4):694–696. doi: 10.1111/j.1476-5381.1977.tb07563.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Jones R. L., Wilson N. H. Partial agonism of prostaglandin H2 analogs and 11-deoxy-prostaglandin F2 alpha to thromboxane-sensitive preparations. Adv Prostaglandin Thromboxane Res. 1980;6:467–475. [PubMed] [Google Scholar]
  13. MAIN I. H. THE INHIBITORY ACTIONS OF PROSTAGLANDINS ON RESPIRATORY SMOOTH MUSCLE. Br J Pharmacol Chemother. 1964 Jun;22:511–519. doi: 10.1111/j.1476-5381.1964.tb01705.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Needleman P., Moncada S., Bunting S., Vane J. R., Hamberg M., Samuelsson B. Identification of an enzyme in platelet microsomes which generates thromboxane A2 from prostaglandin endoperoxides. Nature. 1976 Jun 17;261(5561):558–560. doi: 10.1038/261558a0. [DOI] [PubMed] [Google Scholar]
  15. Nicolaou K. C., Gasic G. P., Barnette W. E. Synthesis and biological properties of prostaglandin endoperoxides, thromboxanes and prostacyclins. Angew Chem Int Ed Engl. 1978 May;17(5):293–312. doi: 10.1002/anie.197802933. [DOI] [PubMed] [Google Scholar]
  16. Nishizawa E. E., Miller W. L., Gorman R. R., Bundy G. L., Svensson J., Hamberg M. Prostaglandin d2 as a potential antithrombotic agent. Prostaglandins. 1975 Jan;9(1):109–121. doi: 10.1016/s0090-6980(75)80122-5. [DOI] [PubMed] [Google Scholar]
  17. Samuelsson B., Hamberg M., Malmsten C., Svensson J. The role of prostaglandin endoperoxides and thromboxanes in platelet aggregation. Adv Prostaglandin Thromboxane Res. 1976;2:737–746. [PubMed] [Google Scholar]
  18. Svenssen J., Strandberg K., Tuvemo T., Hamberg M. Thromboxane A2: effects on airway and vascular smooth muscle. Prostaglandins. 1977 Sep;14(3):425–436. doi: 10.1016/0090-6980(77)90258-1. [DOI] [PubMed] [Google Scholar]
  19. Svensson J., Hamberg M., Samuelsson B. On the formation and effects of thromboxane A2 in human platelets. Acta Physiol Scand. 1976 Nov;98(3):285–294. doi: 10.1111/j.1748-1716.1976.tb10313.x. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES